Can Selective Serotonin Reuptake Inhibitors (SSRIs) and Buspar (buspirone) be used together for anxiety management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, SSRIs and buspirone can be used together for anxiety management, as they have complementary mechanisms of action and can provide more comprehensive anxiety relief than either medication alone. This combination is commonly prescribed when an SSRI alone doesn't provide adequate symptom relief. SSRIs such as sertraline (Zoloft), escitalopram (Lexapro), or fluoxetine (Prozac) typically serve as first-line treatments at their standard dosages, while buspirone is usually started at 7.5-15mg twice daily and can be gradually increased to 30-60mg daily in divided doses.

The most recent and highest quality study, 1, suggests that SSRIs have a high response rate, with a number needed to treat (NNT) of 4.70, and a similar rate of treatment discontinuation as placebo, indicating a high safety profile. Although this study does not specifically address the combination of SSRIs and buspirone, it does provide evidence for the efficacy and safety of SSRIs in anxiety management.

Some key points to consider when using this combination include:

  • Starting with a low dose of buspirone and gradually increasing as needed
  • Monitoring for potential side effects, such as dizziness, headache, or nausea
  • Informing patients that effects may take 2-4 weeks to become noticeable
  • Regularly assessing the patient's response to treatment and adjusting the dosage or medication regimen as needed

It's also important to note that the Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychology clinical practice guideline for social anxiety disorder, 1 and 1, recommends SSRIs as a first-line treatment for social anxiety disorder, but does not specifically address the use of buspirone in combination with SSRIs. However, the guideline does provide evidence for the efficacy and safety of SSRIs in anxiety management, which supports the use of this combination.

In general, the combination of SSRIs and buspirone is a common and effective approach to anxiety management, and can be used in a variety of situations, including when an SSRI alone is not providing adequate symptom relief. As with any medication combination, it's essential to carefully monitor the patient's response to treatment and adjust the dosage or medication regimen as needed to minimize potential side effects and maximize efficacy.

From the Research

Combination Therapy for Anxiety Management

  • Selective Serotonin Reuptake Inhibitors (SSRIs) and Buspar (buspirone) are both used to treat anxiety disorders, but their mechanisms of action differ 2, 3, 4.
  • SSRIs, such as sertraline and paroxetine, work by increasing serotonin levels in the brain, while buspirone acts as a 5-HT1A receptor partial agonist 2, 3.
  • There is evidence to suggest that combining SSRIs with buspirone may be effective in treating certain anxiety disorders, such as generalized anxiety disorder 5, 3.
  • However, there is also a risk of serotonin syndrome when combining buspirone with other serotonergic drugs, such as fluoxetine 6.

Potential Benefits and Risks

  • The combination of SSRIs and buspirone may offer an advantage in treating anxiety disorders by modulating both serotonin and noradrenaline systems 2.
  • Buspirone has been shown to be effective in treating generalized anxiety disorder without the sedative effects of benzodiazepines 3, 4.
  • However, the risk of serotonin syndrome must be carefully considered when combining buspirone with other serotonergic drugs 6.

Clinical Considerations

  • Clinicians should carefully evaluate the potential benefits and risks of combining SSRIs and buspirone for anxiety management 2, 6.
  • Patients should be closely monitored for signs of serotonin syndrome, such as confusion, diaphoresis, and myoclonus, when taking this combination 6.
  • Further studies are needed to fully understand the efficacy and safety of combining SSRIs and buspirone for anxiety management 2, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders.

International journal of psychiatry in clinical practice, 2006

Research

Buspirone, a new approach to the treatment of anxiety.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1988

Research

Buspirone: Back to the Future.

Journal of psychosocial nursing and mental health services, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.